[Breast Cancer: Targets and Therapy] This review focuses on understanding how breast cancer responds to treatment and how resistance develops.
A recent analysis of insurance claims data revealed trends in ED visits, ICU visits, hospitalizations, and antineoplastic treatment at the end of life in this population.
A literature review showed strategies for managing oral mucosal AEs in this patient population, including the role of dentists in a multidisciplinary team.
The use of textured breast implants for breast reconstruction was associated with increased risk of breast cancer recurrence, warranting further study.
Use may be best reserved for those at high risk of recurrence.
The approval was based on data from the phase 3 KEYNOTE-355 trial that pembrolizumab plus chemotherapy in adults with locally recurrent inoperable or metastatic TNBC, who had not been previously treated with chemotherapy in the metastatic setting.
Cancer detection rate higher for repeat screening with digital breast tomosynthesis + synthetic mammography versus full-field digital mammography.
Mortality reduced for patients with newly diagnosed breast, colorectal, lung cancers, mediated by earlier stage of diagnosis.
Association between delay and increased mortality significant for 13 of 17 indications.
[Breast Cancer: Targets and Therapy] This review summarizes current knowledge of predictors and prognostic biomarkers of this rare and highly aggressive subtype of breast cancer.